Leuprolide Clinical Trials

7 actively recruiting trials across 6 locations

Also known as: Leuprolide Depot, Leuprorelin

Filter by location:

Birmingham, Alabama2 trials

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Central Alabama Research

Phase 3

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

University of Alabama at Birmingham Cancer Center

Phase 3

Phoenix, Arizona1 trial

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Mayo Clinic in Arizona

Phase 2

Atlanta, Georgia1 trial

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

Emory Proton Therapy Center

Phase 3

Boston, Massachusetts1 trial

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Brigham and Women's Hospital

Phase 2

Ann Arbor, Michigan1 trial

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

University of Michigan Comprehensive Cancer Center

Phase 2

Columbus, Ohio1 trial

Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

Ohio State University Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.